Literature DB >> 9000221

Formation of taste aversion and preference in protein synthesis inhibition in rats.

O N Serova1, N A Solov'ea, L V Lagutina, M F Obukhova.   

Abstract

The investigation was devoted to the role of the synthesis of protein and peptide factors during the formation of chemosensory memory in rats. Two models of gustatory memorization were used: conditioned taste aversion (CTA), induced by the association of the taste of saccharine with a toxic injection of lithium chloride, and enhanced taste preference (ETP), induced by the influence of preliminary drinking of a saccharine solution on its repeat consumption. It was found that, under conditions of the inhibition of protein synthesis in the brain of 43% by cycloheximide and of 59% by 8-azaguanine, CTA does not form. ETP does not form under the influence of cycloheximide, but not [sic] of 8-azaguanine. A hypothesis was advanced regarding the participation of a varied spectrum of protein and peptide substances in the formation of taste aversion and preference. An influence of protein synthesis blockers on the process of retrieval of gustatory memory was not found.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9000221     DOI: 10.1007/bf02359410

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  3 in total

Review 1.  The gustatory system in mammals.

Authors:  R Norgren
Journal:  Am J Otolaryngol       Date:  1983 Jul-Aug       Impact factor: 1.808

2.  Why do sugars taste good?

Authors:  I Ramirez
Journal:  Neurosci Biobehav Rev       Date:  1990       Impact factor: 8.989

3.  Protein synthesis inhibition and amnesia for saccharin aversion memory in rats after intra-cisternal administration of cycloheximide.

Authors:  A R Tucker; T P Oei
Journal:  Physiol Behav       Date:  1982-06
  3 in total
  1 in total

1.  Late Protein Synthesis-Dependent Phases in CTA Long-Term Memory: BDNF Requirement.

Authors:  Araceli Martínez-Moreno; Luis F Rodríguez-Durán; Martha L Escobar
Journal:  Front Behav Neurosci       Date:  2011-09-22       Impact factor: 3.558

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.